Lumida
/ATRC
⌘K
AtriCure Inc

AtriCure Inc

ATRC
$54.54USD+2.98%+1.58 today

MARKET CAP

2.8B

P/E (TTM)

FWD P/E

DAY RANGE

$54 – $55

52W RANGE

$25
$56

AI Summary

Stalk
StalkMedium

ATRC has broken to a new 52-week high in a strong uptrend, confirmed by volume and momentum, but overbought conditions and stretched valuations warrant patience for a pullback into the rising EMA zone before engaging.

  • 2025 revenue $534M (+15% YoY) driven by AtriClip Flex Mini, CryoSphere Max
  • Pain management sales up 28% in 2025 on CryoSphere Max adoption
  • Negative earnings yield and weak profitability metrics signal return challenges
Full analysis →

Buying

7

institutions

Selling

7

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY4.47 M125.20 M+431.87 K+8.6%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

BUYNEW604.38 K16.91 M+604.38 K+0.0%0.02%
AC

Aqr Capital Management LLC

Q2 2026

BUY544.12 K15.22 M+357.74 K+186.3%0.01%
RT

Renaissance Technologies LLC

Q2 2026

SELL234.10 K6.55 M+-74.60 K-25.6%0.01%
CA

Citadel Advisors LLC

Q2 2026

BUY188.84 K5.28 M+101.49 K+112.0%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL160.39 K4.67 M+-10.87 K-3.6%0.00%
BA

Bridgewater Associates, LP

Q2 2026

BUY76.31 K2.14 M+42.79 K+123.3%0.01%
BH

Brevan Howard Capital Management LP

Q2 2026

BUY54.45 K1.52 M+44.95 K+462.1%0.01%
VI

Voloridge Investment Management, LLC

Q2 2026

SELL50.58 K1.42 M+-46.60 K-49.0%0.01%
JH

Janus Henderson Group Plc

Q1 2026

BUY45.77 K1.31 M+22.88 K+44.3%0.00%
MG

Man Group Plc

Q2 2026

SELL24.44 K683.91 K+-60.67 K-71.8%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL3.51 K98.10 K+-1.41 K-30.0%0.00%
MM

Millennium Management LLC

Q2 2026

SELL0.000.00+-179.89 K-100.0%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL0.000.00+-17.30 K-100.0%0.00%